BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang MTM, Danesh-Meyer HV. Cannabinoids and the eye. Surv Ophthalmol 2021;66:327-45. [PMID: 32763339 DOI: 10.1016/j.survophthal.2020.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zantut PRA, Veras MM, Benevenutto SGM, Safatle AMV, Pecora RA, Yariwake VY, Torres JI, Sakuno G, Martins MAG, Bolzan AA, Takahashi WY, Saldiva PHN, Damico FM. Lasting effects of prenatal exposure to Cannabis in the retina of the offspring: an experimental study in mice. Int J Retina Vitreous 2021;7:45. [PMID: 34193310 DOI: 10.1186/s40942-021-00314-8] [Reference Citation Analysis]
2 Ali A, Gupta PK. Change in Refractive Error Associated With the Use of Cannabidiol Oil. Cureus 2021;13:e14434. [PMID: 33996300 DOI: 10.7759/cureus.14434] [Reference Citation Analysis]
3 Stella B, Baratta F, Della Pepa C, Arpicco S, Gastaldi D, Dosio F. Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs 2021;81:1513-57. [PMID: 34480749 DOI: 10.1007/s40265-021-01579-x] [Reference Citation Analysis]
4 Nicou CM, Pillai A, Passaglia CL. Effects of acute stress, general anesthetics, tonometry, and temperature on intraocular pressure in rats. Exp Eye Res 2021;210:108727. [PMID: 34390732 DOI: 10.1016/j.exer.2021.108727] [Reference Citation Analysis]
5 Jordan E, Nguyen GN, Piechot A, Kayser O. Cannabinoids as New Drug Candidates for the Treatment of Glaucoma. Planta Med 2022. [PMID: 35299275 DOI: 10.1055/a-1665-3100] [Reference Citation Analysis]
6 Passani A, Posarelli C, Sframeli AT, Perciballi L, Pellegrini M, Guidi G, Figus M. Cannabinoids in Glaucoma Patients: The Never-Ending Story. J Clin Med 2020;9:E3978. [PMID: 33302608 DOI: 10.3390/jcm9123978] [Cited by in F6Publishing: 3] [Reference Citation Analysis]